Literature DB >> 16934196

Severe skin and soft tissue infections and associated critical illness.

Donald C Vinh, John M Embil.   

Abstract

Skin and soft tissue infections (SSTIs) span a broad spectrum of clinical entities from limited cellulitis to rapidly progressive necrotizing fasciitis, which may be associated with septic shock or a toxic shock-like syndrome. These infections may manifest initially as pyodermas that then progress; alternatively, they may arise from metastatic spread of microorganisms from a distant focus. Regardless of the source, SSTIs may lead to critical illness. The complex interplay of environment, host, and pathogen are important to consider when evaluating SSTIs and planning appropriate therapy. The keys to a successful outcome are early identification of risk factors for specific pathogens and early initiation of empiric antimicrobial therapy. For certain types of SSTIs, surgical intervention for diagnosis and/or therapy is also required.

Entities:  

Year:  2006        PMID: 16934196     DOI: 10.1007/s11908-006-0048-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  56 in total

Review 1.  Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis?

Authors:  A Smith; T L Lamagni; I Oliver; A Efstratiou; R C George; J M Stuart
Journal:  Lancet Infect Dis       Date:  2005-08       Impact factor: 25.071

2.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Authors:  R Kaul; A McGeer; A Norrby-Teglund; M Kotb; B Schwartz; K O'Rourke; J Talbot; D E Low
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

Review 3.  Is plasminogen deployed as a Streptococcus pyogenes virulence factor?

Authors:  Mark J Walker; Jason D McArthur; Fiona McKay; Marie Ranson
Journal:  Trends Microbiol       Date:  2005-07       Impact factor: 17.079

Review 4.  Uncovering the mysteries of invasive streptococcal diseases.

Authors:  Gursharan S Chhatwal; David J McMillan
Journal:  Trends Mol Med       Date:  2005-04       Impact factor: 11.951

5.  Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.

Authors:  J Zimbelman; A Palmer; J Todd
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

6.  Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.

Authors:  Hongmin Sun; Ulrika Ringdahl; Jonathon W Homeister; William P Fay; N Cary Engleberg; Angela Y Yang; Laura S Rozek; Xixi Wang; Ulf Sjöbring; David Ginsburg
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

7.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

8.  M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage.

Authors:  Heiko Herwald; Henning Cramer; Matthias Mörgelin; Wayne Russell; Ulla Sollenberg; Anna Norrby-Teglund; Hans Flodgaard; Lennart Lindbom; Lars Björck
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

9.  Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.

Authors:  N Markowitz; E L Quinn; L D Saravolatz
Journal:  Ann Intern Med       Date:  1992-09-01       Impact factor: 25.391

10.  Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

Authors:  Mark E Jones; James A Karlowsky; Deborah C Draghi; Clyde Thornsberry; Daniel F Sahm; Dilip Nathwani
Journal:  Int J Antimicrob Agents       Date:  2003-10       Impact factor: 5.283

View more
  3 in total

1.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

2.  Multidisciplinary management of periocular necrotising fasciitis: a series of 11 patients.

Authors:  K Tambe; A Tripathi; J Burns; R Sampath
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

3.  Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.

Authors:  Wanda C Reygaert
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.